[ sulge aken ]
| Elulookirjeldus (CV) | ||
| 1. | Eesnimi | Alar |
| 2. | Perekonnanimi | Veraksitš |
| 3. | Töökoht | Tartu Ülikool Füsioloogia instituut |
| 4. | Ametikoht | Assitent |
| 5. | Sünniaeg | 25.06.1967 (päev.kuu.aasta) |
| 6. | Haridus | Kõrgharidus |
| 7. | Teenistuskäik | Alates 2002 Füsioloogi instituudis assistent. 1998-2002 Doktorantuur TÜ Spordimeditsiini ja taastusravi kliinikus. 1997-98/99 Teadustööl Füsioloogia ja farmakoloogia osakonnas Karolinska Instituudis Stockholmis. 1996 - 1997. Nooremarstina Pärnu haiglas ning sanatooriumides “Pärnu Mudaravila” ja “Viiking”. |
| 8. | Teaduskraad | Doctor Medicinae |
| 9. | Teaduskraadi välja andnud asutus, aasta |
Tartu Ülikool 2003 |
| 10. | Tunnustused | Arstiteaduskonna konverentsi preemia 2000. “Helga ja Helmut Einpauli Mälestusfondi” stipendium 2000. “Liisa Kolumbuse Mälestusfondi” stipendium 1999. |
| 11. | Teadusorganisatsiooniline ja –administratiivne tegevus |
|
| 12. | Juhendamisel kaitstud väitekirjad |
|
| 13. | Teadustöö põhisuunad | 1. Koletsüstokiniini ja teiste neuropeptiidide roll negatiivsete emotsioonide ja valu mehhansimides. 2. Angiotensiini konverteeriva ensüümi (angiotensin converting enzyme - ACE) geeni I/D polümorfismi seos kardiovaskulaarsüsteemi seisundiga ja üldise füüsilise võimekusega. 3. Kortikotropiini vabastava faktori (CRF) toime tursele perifeersetes kudedes ja selle sõltuvus perifeerse närvisüsteemi terviklikkusest. |
| 14. | Jooksvad grandid | |
| 15. | Teaduspublikatsioonid |
The International XVIII Puijo Symposium “Skeletal Muscle Metabolism and Chronic Diseases", Kuopio Finland 2005 “The effect of coenzyme Q on the results of early exercise program after acute myocardial infarction” Lukmann A, Ojamaa M,Veraksitch A, Vihalemm T, Zilmer K, Zilmer M,Maaroos J. Behavioural Brain Research 2003, 144, 125–135 “Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice” K.Rünkorg, A.Veraksitš, K.Kurrikoff, H.Luuk, S.Raud, U.Abramov, T.Matsui, M.Bourin, S.Kõks, E.Vasar Dissertationes Medicinae Universitas Tartuensis; Tartu 2003 “Characterization of behavioural and biochemical phenotype of cholecystokinin 2 receptor-deficient mice: changes in the function of the dopamine– and endopioidergic system” A.Veraksitš Nephrol Dial Transplant 2003 Mar 18:3 624-5 “Regular Low-intensity Aquatic Exercise Improves Cardiorespiratory Functional Capacity and Reduces Proteinuria in Chronic Renal Failure Patients “ Ü Pechter, J Maaroos, S Mesikepp, A Veraksitš, M Ots Neuropeptides, 2003, 37, 25-29. “CCK2 receptors deficient mice have increased sensitivity of dopamin D2 receptors” S. Kõks, U. Abramov, A. Veraksitš, T. Matsui, M. Bourin, E. Vasar Psychopharmacology (Berl) 2003 Aug 168:4 417-25 “Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice.” S Raud, K Rünkorg, A Veraksitš, A Reimets, A Nelovkov, U Abramov, T Matsui, M Bourin, V Volke, S Koks, E Vasar. Psychopharmacology (Berl) 2003 Mar 166:2 168-75. “Altered pain sensitivity and morphine-induced antinociception in mice lacking CCK2 receptors” A. Veraksitš, K. Rünkorg, K. Kurrikoff, S. Raud, U. Abramov, T. Matsui, M. Bourin, S. Kõks, E. Vasar Eur Psychiatry 2002 May 17 Suppl 1: 50 “Mice lacking CCK2 receptors display reduced anxiety in the plus-maze.” E. Vasar, S. Raud, A. Veraksitš, K. Rünkorg, T. Matsui, M. Bourin, C.J. Greengrass, V. Volke, S. Kõks “ACE gene I/D polymorphism is affecting improvement of oxygen consumption at patients with myocardial revascularisation.” Alar Veraksitš, Aet Lukmann, Eero Vasar, Jaak Maaroos Psychopharmacology (2001) 158; 198-204 “CCK2 receptors deficient mice display altered function of brain dopaminergic system” S Koks,V Volke, A Veraksitš, K Rünkorg, T Sillat, U Abramov, M Bourin, M Huotari, PT Mannisto, T Matsui, E Vasar Terapevtitšeskii Arhiv (Moskva, vene keelne) “Varase taastusravi tulemused südame isheemiatõvest tuleneva südame puudulikkusega patsientidel, pärast südamelihase verevarustuse kirurgilist taastamist.” A Lukmann-Arak, J Maaroos, A Landõr; A Veraksitš “ACE geeni polümorfismi seostest südamelihase ja skeletilihase arenguga ning kardiorespiratoorse reservi ja kehalise töövõimega” Alar Veraksitš, Eevi Maiste, Tiia Bakler Neuropeptides Vol. 34, nr. 2, aprill 2000 ja abstrakt IASP-i 9-nda kongressi kataloogis. “Neuronal mechanisms contribute to corticotropin-releasing factor (CRF)-induced anti-oedema effect in the rat hind paw.” A Veraksitš, I Bileviciute-Ljungar, J Maaroos, E Vasar, T Lundeberg Papers in Anthropology 9 2000 Tartu. “The association of body composition with left ventricular morfometry in young healthy male subjects.” T Bakler, A Veraksitš, E Maiste. Proc. of the Dep. of Cardiology at the University of Tartu. “Left ventricular mass and left ventricular geometry of physical active youngsters with and without juvenile hypertension.” Eevi Maiste, Tiia Bakler, Alar Veraksitš |
viimati muudetud: 05.10.2005
| Curriculum Vitae (CV) | ||
| 1. | First Name | Alar |
| 2. | Surname | Veraksitš |
| 3. | Institution | University of Tartu Department of Physiology |
| 4. | Position | Assistant |
| 5. | Date of birth | 25.06.1967 (day.month.year) |
| 6. | Education | Medical doctor |
| 7. | Research and professional experience |
since 2002 Assistant at the Dep.of Physiology,UT 1998-02 Dep.of Sports Medicine and Rehabilitation, UT 1997-98/99 Researcher, Dep.of Physiology and Pharmacology in the Karolinska Institute in Stockholm, Sweden ; 1996-97 Medical doctor in Pärnu Hospital and at the rehabilitation centres “Pärnu Mudaravila” and “Viiking” |
| 8. | Academic degree | Doctor Medicinae |
| 9. | Dates and sites of earning the degrees |
University of Tartu 2003 |
| 10. | Honours/awards | Scientific award of annual conference of the Medical Faculty of University of Tartu 2000. Stipend from the “Helga and Helmut Einpaul Memorial Foundation” 2000. Stipend from the “Liisa Kolumbuse Memorial Foundation” 1999. |
| 11. | Research-administrative experience |
|
| 12. | Supervised dissertations | |
| 13. | Current research program | 1. Role of CCK and other neuropeptides in generation of negative emotions and in control of pain. 2. Role of the I/D polymorphism in the Angiotensin Converting Enzyme (ACE) gene in humans. 3. Role of the Corticotrophin Releasing Factor (CRF) in localised inflammation. |
| 14. | Current grant funding | |
| 15. | List of most important publications |
The International XVIII Puijo Symposium “Skeletal Muscle Metabolism and Chronic Diseases", Kuopio Finland 2005 “The effect of coenzyme Q on the results of early exercise program after acute myocardial infarction” Lukmann A, Ojamaa M,Veraksitch A, Vihalemm T, Zilmer K, Zilmer M,Maaroos J. Behavioural Brain Research 2003, 144, 125–135 “Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice” K.Rünkorg, A.Veraksitš, K.Kurrikoff, H.Luuk, S.Raud, U.Abramov, T.Matsui, M.Bourin, S.Kõks, E.Vasar Dissertationes Medicinae Universitas Tartuensis; Tartu 2003 “Characterization of behavioural and biochemical phenotype of cholecystokinin 2 receptor-deficient mice: changes in the function of the dopamine– and endopioidergic system” A.Veraksitš Nephrol Dial Transplant 2003 Mar 18:3 624-5 “Regular Low-intensity Aquatic Exercise Improves Cardiorespiratory Functional Capacity and Reduces Proteinuria in Chronic Renal Failure Patients “ Ü Pechter, J Maaroos, S Mesikepp, A Veraksitš, M Ots Neuropeptides, 2003, 37, 25-29. “CCK2 receptors deficient mice have increased sensitivity of dopamin D2 receptors” S. Kõks, U. Abramov, A. Veraksitš, T. Matsui, M. Bourin, E. Vasar Psychopharmacology (Berl) 2003 Aug 168:4 417-25 “Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice.” S Raud, K Rünkorg, A Veraksitš, A Reimets, A Nelovkov, U Abramov, T Matsui, M Bourin, V Volke, S Koks, E Vasar. Psychopharmacology (Berl) 2003 Mar 166:2 168-75. “Altered pain sensitivity and morphine-induced antinociception in mice lacking CCK2 receptors” A. Veraksitš, K. Rünkorg, K. Kurrikoff, S. Raud, U. Abramov, T. Matsui, M. Bourin, S. Kõks, E. Vasar Eur Psychiatry 2002 May 17 Suppl 1: 50 “Mice lacking CCK2 receptors display reduced anxiety in the plus-maze.” E. Vasar, S. Raud, A. Veraksitš, K. Rünkorg, T. Matsui, M. Bourin, C.J. Greengrass, V. Volke, S. Kõks “ACE gene I/D polymorphism is affecting improvement of oxygen consumption at patients with myocardial revascularisation.” Alar Veraksitš, Aet Lukmann, Eero Vasar, Jaak Maaroos Psychopharmacology (2001) 158; 198-204 “CCK2 receptors deficient mice display altered function of brain dopaminergic system” S Koks,V Volke, A Veraksitš, K Rünkorg, T Sillat, U Abramov, M Bourin, M Huotari, PT Mannisto, T Matsui, E Vasar Terapevtitšeskii Arhiv (Moskva, vene keelne) “Varase taastusravi tulemused südame isheemiatõvest tuleneva südame puudulikkusega patsientidel, pärast südamelihase verevarustuse kirurgilist taastamist.” A Lukmann-Arak, J Maaroos, A Landõr; A Veraksitš “ACE geeni polümorfismi seostest südamelihase ja skeletilihase arenguga ning kardiorespiratoorse reservi ja kehalise töövõimega” Alar Veraksitš, Eevi Maiste, Tiia Bakler Neuropeptides Vol. 34, nr. 2, aprill 2000 ja abstrakt IASP-i 9-nda kongressi kataloogis. “Neuronal mechanisms contribute to corticotropin-releasing factor (CRF)-induced anti-oedema effect in the rat hind paw.” A Veraksitš, I Bileviciute-Ljungar, J Maaroos, E Vasar, T Lundeberg Papers in Anthropology 9 2000 Tartu. “The association of body composition with left ventricular morfometry in young healthy male subjects.” T Bakler, A Veraksitš, E Maiste. Proc. of the Dep. of Cardiology at the University of Tartu. “Left ventricular mass and left ventricular geometry of physical active youngsters with and without juvenile hypertension.” Eevi Maiste, Tiia Bakler, Alar Veraksitš |
last updated: 05.10.2005
[ sulge aken ]